Dimethylformamide → 1,2,3,4-Tetrahydro-3-(3,4-methylenedioxyphenyl)-2-(pyridin-4-yl)methyl-9H-pyrrolo-[3,4-b]quinolin-9-one
Reaktionsgleichung
[H-].[Na+].[CH2:3]1[O:11][C:10]2[CH:9]=[CH:8][C:7]([CH:12]3[C:24]4[NH:23][C:22]5[C:17](=[CH:18][CH:19]=[CH:20][CH:21]=5)[C:16]=4[CH2:15][CH2:14][N:13]3[CH2:25][C:26]3[CH:31]=[CH:30][N:29]=[CH:28][CH:27]=3)=[CH:6][C:5]=2[O:4]1.CN(C=[O:36])C>>[CH2:3]1[O:11][C:10]2[CH:9]=[CH:8][C:7]([CH:12]3[C:24]4[NH:23][C:22]5[CH:21]=[CH:20][CH:19]=[CH:18][C:17]=5[C:16](=[O:36])[C:15]=4[CH2:14][N:13]3[CH2:25][C:26]3[CH:31]=[CH:30][N:29]=[CH:28][CH:27]=3)=[CH:6][C:5]=2[O:4]1Komponenten
4
Versuchsvorschrift
Following the same procedure as outlined in Example 21, sodium hydride (60% in mineral oil, 40 mg, 1.0 mmol) and 1-(3,4-methylenedioxyphenyl)-2-(pyridin-4-yl)methyl-2,3,4,9-tetrahydro-1H-β-carboline (192 mg, 0.50 mmol) (prepared as in Example 15) in DMF (10 mL, anhydrous) were reacted to yield the product as a white solid.
Aufarbeitung
- customwere reacted
Quellen und Nachweise
- ORD-Eintrag
- ord-5e2a79271e1b4e9c8276242ef27c0253
- Quelldatensatz
- uspto-grants-2004_11
- Patentnummer
- US06818646B2
Notizen zur Reaktion
Wird geladen…